I agree with you. I also think we are all dissecting this way too much. Most likely they left things as open as possible and getting rid of people to allow for the most optimal scenario financially to carry on. And from the looks of the research and additional companies added with ligands, etc.. I think they have a decent pathway with better management. I have no doubt they will carry on , however it is all just how much everyone thinks it is worth at this very second.
Market Data 
Markets 
AI
